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Abstract 
 
In July 2017 the Society for Experimental Biology hosted a symposium on New 
Breeding Technologies (NBTs) in Plant Sciences at the University of Gothenburg. This 
report summarises the major outcomes of this meeting. Delegates discussed both the 
technical and policy aspects of NBTs, with a focus on CRISPR-Cas9 gene editing. While 
NBTs have the potential to revolutionise the future generation of new crop varieties, a 
major outcome of the meeting was the acceptance that we are at a critical juncture 
regarding the policy decisions that will govern the future use of plants generated using 
these technologies. This meeting report offers insights into how scientists can frame their 
input into the upcoming debate, as well as a discussion about what is technically possible 
with NBTs.  
 
 
 
The use of the CRISPR-Cas9 system for precision genome editing (GE) has been 
regularly described as a “game-changing technology” that allows a more precise targeting 
of DNA to induce specific nucleotide variations (Belhaj et al. 2015); however, the use of GE 
in plants for the production of food or feed still faces an uncertain regulatory future. This 
follows on from a long-standing public distrust of genetically modified organisms (GMOs), 
an opinion predicated from, amongst other things, controversial yet discredited scientific 
studies and public miscommunications. Public unease with this technology has guided 
government policy on the permitted uses of the products of GMOs, such that growth of 
these crops is now restricted throughout most of the EU. The plant science community 
stands at an important crossroads at which the future uses of plants generated by GE 
technologies will be decided. 
 
This issue was a primary concern for the group of 70 international delegates who 
met in Gothenburg, Sweden, for the Society for Experimental Biology Plant Section 
Symposium on New Breeding Technologies in July 2017. This meeting was organized in 
collaboration with the Global Plant Council, GARNet, the Scandinavian Plant Physiology 
Society, and the Australian Society of Plant Scientists, and brought together experts on both 
the regulatory and technical aspects of using CRISPR-Cas9, the most popular type of GE 
technology. This special issue of Physiologica Plantarum includes articles from meeting 
participants on a variety of topics that were discussed at this meeting. 
 
Outdated regulations and delayed decisions 
 
There have been continued delays with the EU decision that will confirm the 
Europe-wide regulatory status of crops modified using GE technologies (Nature Editorial 
2017). The problems caused by this delay were highlighted by Joachim Schiemann (Julius 
Kühn-Institut) and Petra Jorasch (European Seed Association) who, speaking during the 
session entitled ‘Policy and Legislative Implications for Use of Gene Editing Technologies’, 
stated that their own interactions with academics and businesses have confirmed that the 
current uncertainty is inhibiting innovation. Researchers are unable to make long-term 
plans to develop products from GE plants as they do not know whether the growth of these 
plants will be permitted in the future. 
 
In the same session, Piet van der Meer (Ghent University, Free University of 
Brussels) provided an overview of biosafety legislation, including a historical discussion 
regarding which organisms should be subject to risk assessment. He questioned whether 
this should include all conventionally produced organisms or only ‘novel’ organisms, and 
pondered the follow-on assessment of what exactly defines ‘novelty’? Looking to the future, 
it could be argued that GE crops might be covered by existing regulations on the 
modification process, given that they are often produced by Agrobacterium-mediated gene 
transfer; however, as the final GE plant is often indistinguishable from those generated by 
conventional mutagenesis-driven breeding, should they really be subject to different 
regulations? 
  
The question remains whether these crops are ‘novel’ and should be regulated 
differently. The current EU definition of a GMO states that it is ‘an organism in which the 
genetic material has been altered in a way that does not occur naturally’. As this definition 
relies on material containing a level of novelty resulting from the combination of genetic 
material from sexually incompatible species, Piet van der Meer concluded that a crop plant 
containing only a small nucleotide change obtained via GE should not fall within the remit 
of this legislation. Policymakers around the world are currently battling with these types of 
technical and semantic descriptions, and an overview of the ways in which different 
countries have tackled these arguments was discussed at length during the meeting (see 
section below). 
 
 
Focus on product not process  
 
The complexity of the future regulatory environment was summarised by Petra 
Jorasch, who highlighted the different types of GE that might need to be legislated upon 
(Figure 1). During his presentation, Joachim Schiemann presented the key questions that 
will be deliberated by EU decision makers: ‘Are gene edits different from those that might 
occur during natural processes?’ and ‘Are edits distinguishable from those that occur 
spontaneously in nature or by conventional cross breeding?’. Schiemann reported that, in 
May 2017, the European Academics Science Advisory Committee (EASAC) recommended 
that the products of GE technologies that do not contain DNA from an unrelated organism 
should not fall under the scope of current GMO regulations (EASAC 2017). In addition, the 
EASAC report states that, where the method of production is fully transparent and no novel 
product-based risks are identified, the products of GE should be regulated on the basis of 
the agricultural trait modified, rather than its method of production.   
 
A common theme of discussion during the meeting considered how regulations 
might keep pace with future technological changes. Barry Pogson (Australian National 
University) highlighted that many current GMO regulations are 20 years old and are no 
longer fit for purpose given the technological advances that have occurred over that time 
period. Ruth Bastow (Global Plant Council) asked the group to not only consider how 
regulations can be retrofitted to new technologies, but also how scientists can set the 
agenda regarding the ways in which their future research might be regulated. Piet van der 
Meer challenged researchers to go to regulators with fully documented descriptions of the 
crop varieties they have generated and ask them to make a de novo judgement on what has 
been done. This would put the onus on regulators to keep pace with the science and not, as 
for the current system for GMOs, limit researchers by guidelines that largely legislate on 
the method of production rather than the final outcome. Attila Molnar (University of 
Edinburgh) provided an outstanding example of this approach; he contacted ‘Science and 
Advice for Scottish Agriculture’ and asked them to consider a CRISPR-Cas9 technology 
developed in his lab that has the potential to generate virus-resistant crops. 
 
Science communicator Craig Cormick (ThinkOutsideThe) led an extended 
discussion regarding the importance of scientists engaging with the court of public opinion 
to discuss the use of GE technology. As the public can have significant influence on future 
political policy, he posited that these interactions do not just have prosaic value; therefore, 
persuading the public that a particular technology is safe might be an important avenue for 
influencing politicians. The early framing of the debate is key when influencing public and 
political will, and scientists need to learn from mistakes that were made in early 
discussions concerning the use of genetic modification for crop improvement. Cormick’s 
own research showed that there are outliers in any general population who will either 
always support or oppose the technology; however, there is crucially also an enormous 
middle-ground of people who can be convinced to accept the use of technology, if the 
argument is properly framed. On the debate surrounding the regulation of GE crops, 
Cormick suggested that focusing on ‘product not process’ might be a useful strategy. Much 
of the anti-GM attitude results from an opposition to a process that is considered 
‘unnatural’; therefore, in this case it might be a useful strategy to provide the explanation 
that GE is simply an evolution of techniques that have been used over millennia to apply 
changes to genomes, and focus on what can be achieved.  
 
The global regulation of GE crops 
 
Plants generated by GE are providing countries with many challenging decisions 
regarding their legislation. The many types of modifications that can be achieved using GE 
have led researchers to call for the legislation of the final product, which can be 
indistinguishable from conventionally bred cultivars, not the process used to develop it. 
Elsewhere in this special issue of Physiologia Plantarum Barry Pogson introduces the 
Global Plant Council statement on the role of GE in plant science and agriculture, which was 
developed during and after the meeting by an international team of experts. Staffan Eklöf, 
an administrative officer at the Swedish Board of Agriculture, told the conference how he 
and his team had worked with scientists to interpret whether GE plants are regulated by 
the current EU legislation on GMOs, determining that plants carrying foreign DNA are 
regulated, whereas those containing mutations that could have occurred “naturally” are 
not. This promising outcome in Sweden has been met with interest by policymakers and 
scientists alike, both in Europe and around the world (for a more in-depth view of the 
regulatory landscape in Europe and Sweden, see associated articles in this special issue of 
Physiologia Plantarum). Evidence of the permissive Swedish policy on GE crops was for all 
to taste at the conference dinner, where a meal was served that included gene-edited 
cabbage, supplied by the meeting’s local host Stefan Jansson (Figure 2). 
 
 Legislative decisions around GE technologies are still in flux. Pogson described the 
complex story in New Zealand, where a government-owned research institute, Scion, asked 
the Environmental Protection Authority (EPA) whether GMOs created using new breeding 
technologies ZFN-1 and TALENs were regulated by the current GMO legislation. The EPA 
determined that these technologies were similar to other techniques excluded from the 
GMO regulations, and were therefore not regulated by GMO legislation; however, an appeal 
taken to the New Zealand High Court led to the overturn of this decision based on a 
different interpretation of the exclusion in question. Pogson also gave an overview of the 
situation in Australia, where the Food Standards Australia and New Zealand recently 
consulted a wide range of people about whether the Gene Technology Act 2001 is still 
appropriate for use, or whether this 16-year-old legislation should be updated in the light 
of more recent technologies. Submissions were received from over 600 institutions and 
individuals, and the Australian Government is currently consulting a range of stakeholders 
regarding making amendments to their GMO legislation to incorporate GE technologies 
(OGTR, 2016).  
 
 Perhaps the most complicated regulatory system for GE crops of those covered at 
the meeting is that of the USA. Certain new GE crops are not subject to the previous 
regulations that have been applied to GMOs, including a waxy maize cultivar and a 
mushroom that resists browning (USDA 2016a,b). However, as the biotechnology field is 
regulated through a mix of policies administered by three different bodies; the US. 
Department of Agriculture (USDA), the Food and Drug Administration (FDA), and the 
Environmental Protection Agency, it is challenging to precisely define which agency will 
provide decisions on new crop species generated by different methods. Wayne Parrott 
(University of Georgia) explained how all of these agencies can regulate GE crops in 
particular circumstances. Whereas the FDA is currently formulating new policies that will 
affect the future regulation of gene editing, the USDA has, since the Gothenburg meeting, 
dropped proposed rule changes that would have given it regulatory powers over GE crops 
(USDA 2017). This news fits with Wayne Parrott’s optimistic conclusion that, as genome 
changes in GE crops could have occurred naturally, they are unlikely to be overly affected 
by negative regulatory decisions, at least for now. 
 
 Decisions on GE legislation are still largely in flux in many countries. As outlined 
above, the EU and many individual countries are yet to make a definitive statement about 
the regulation of technologies such as CRISPR-Cas9, although Argentina and Canada have 
said that they will regulate crops on a case-by-case basis. These decisions are complex, 
involving the competing interests of many interested parties; the views of scientists, anti-
GMO lobbying groups, farmers, the general public, and potential international trade 
partners must all be considered, posing huge challenges for policymakers around the 
world. 
 
 
Tricks from the bench: Technical aspects for preparing GE plants 
 
The workshop was also planned to provide information to delegates regarding the 
technical challenges that exist in the preparation of GE plants, specifically when using 
CRISPR-Cas9 technology. Wayne Parrott highlighted that a major technical advantage of 
using CRISPR-Cas9 was in the targeting of entire gene families, which has proven 
extremely challenging and/or laborious when using RNA interference technology or 
insertional mutants. Interestingly it emerged that, although Arabidopsis might remain a 
favoured research organism, it is probably not an ideal plant model when using CRISPR-
Cas9 technology. Wendy Harwood (John Innes Centre) reported that her research group 
has often found GE in monocots to be more straightforward than in dicots, particularly 
during attempts to generate non-mosaic plants with germline edits. She discussed their 
successes using CRISPR-Cas9 to generate edited plants in barley, wheat, brassicas, and 
tomato, highlighted that the technology is working very well in their hands. They find that 
the main bottleneck when generating GE plants arises from the poor efficiency of plant 
transformation, which remains a significant challenge (Altpeter et al. 2016). 
 
Laurence Tomlinson works with Jonathan Jones at The Sainsbury Lab, Norwich, and 
provided an overview of the troubleshooting that their lab has undertaken in order to 
optimize the use of CRISPR-Cas9, particularly in Arabidopsis. The highlights of her 
presentation are listed in Box 1, and Laurence has made her entire talk available online.  
 
 
 
BOX 1: Laurence Tomlinson, The Sainsbury Lab, Norwich 
 
 
> They target Cas9 to a locus of interest using two guide RNAs. Ideally these should both 
be targeted to 20 nucleotide sequences near the 5’ region of a gene (Cermak et al. 2017). 
 
> They find that including the dinucleotide ‘GG’ sequence at the 3’ end of the guide RNA 
means it is more effective at inducing sequence-specific mutations. 
> For GE in dicots, they found that using the PolIII promoter provides an optimal 
expression of guide RNAs from a single transcript. 
 
> They use the RPS5 promoter to express Cas9 in Arabidopsis (Tsutsui and Higashiyama 
2017). Importantly, they found that the commonly used constitutive 35S promoter is not 
appropriate for effective germline editing, as it has a low activity in the Arabidopsis 
embryo sac. 
 
> Although Laurence did not recommend any particular software tools for designing 
guide RNAs, she obtained the best results using a mixture of automated and manual 
guide RNA design.  
 
> She strongly advised testing the function of the guide RNAs before undertaking time-
consuming plant transformations. Their lab’s favoured method for pre-testing guide 
RNAs is the T7 endonuclease assay.  
 
> The lab uses the FAST marker system to check for successful transformations (Shimada 
et al. 2010). This removed the need for one generation during the process of identifying 
homozygous edited plants. 
 
Attila Molnar and Mariette Anderson (Swedish University of Agricultural Sciences, 
SLU) provided updates on each of their labs’ work, in which they used CRISPR-Cas9 to 
investigate different aspects of plant biology. Mariette Anderson has worked with an 
industrial partner, Lyckeby, to develop a potato variety that has reduced levels of amylose. 
This was achieved by successfully editing four copies of the GBSS gene (Box 2; Andersson et 
al. 2017). Attila Molnars’ group used CRISPR-Cas9 to introduce a single base deletion into 
the Arabidopsis eLF(iso)4E gene, which subsequently confers viral resistance (Box 3; Pyott 
et al. 2016). 
 
BOX 2: Mariette Anderson, Swedish University of Agricultural Sciences, SLU 
 
> As potato breeding can be very complicated and time consuming, CRISPR-Cas9 is a 
promising tool for generating homozygous tetraploids.  
 
> They used two guide RNAs to target the GBSS gene, which is involved in starch 
synthesis.  
 
> They found an improved mutation rate when they used the potato U6 promoter to 
drive guide RNA expression  
 
> Protoplast transformation allowed the regeneration of transgene-free plantlets. 
 
> Only successful editing of all four copies of GBSS resulted in the amylose-free 
phenotype 
 
> They identified plants with knockouts in all four alleles in 2% of regenerated 
plants 
 
> Surprisingly they found a high proportion of full plasmid insertions at the GE 
target sites. Plantlets containing these insertion were discarded. 
 
BOX 3: Attila Molnar, University of Edinburgh 
 
> They targeted elongation factor eLF(iso)4E in Arabidopsis, which is necessary for 
Potyvirus infection 
 
> They used the T7 endonuclease assay to identify plants that had been successfully edited 
 
> Growing the Arabidopsis plants at higher temperatures sped up the time between 
generations. 
 
> In the T2 generation, they found a 59% mutation frequency in non-transgenic plants. 
 
> Homozygous GE mutants are resistant to Turnip Mosaic Virus and importantly featured 
no growth or yield penalties 
 
Johannes Stuttmann (Martin-Luther Universitat, Halle-Wittenberg) concluded the meeting 
with a description of his work using GE to investigate the defence response in Arabidopsis. 
In addition, he described a set of Dicot Genome Editing (DGE) vectors developed by his 
group and made available to the community (Ordon et al. 2016). These plasmids were 
generated using the golden gate cloning system and allow for the facile multiplexing of four 
guide RNAs. When used successfully, these guide RNAs allow for the targeting of a broader 
range of sequences, thus increasing the chances of obtaining a successful deletion.  
Summary 
 
The New Breeding Technologies symposium focussed on meeting the technical and 
regulatory challenges associated with new GE technologies. Progress is being made more 
rapidly in the successful application of techniques such as CRISPR-Cas9 than in making the 
legislative decisions regarding their use. An important piece of advice that emerged from 
this meeting is that scientists need to take the lead. They should provide guidance for 
policymakers and initiate discussions that result in the development of informed and 
appropriate legislation regarding the use of these revolutionary technologies, which have 
the potential to significantly enhance sustainable food, fibre, and energy production in the 
future. 
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Figure 1. Types of genome manipulation used in plant breeding and cultivar development.  
Image modified from that kindly supplied by Petra Jorasch, European Seed Association 
(www.euroseeds.eu) 
 
 
 
 
 
Figure 2: Gene-edited cabbage was on the menu at the conference dinner (from 
@GARNetweets) 
